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Background: A few prospective studies suggest an association 
between maternal smoking during pregnancy and lower risk of type 1 
diabetes. However, the role of unmeasured confounding and misclas-
sification remains unclear.
Methods: We comprehensively evaluated whether maternal smok-
ing in pregnancy predicts lower risk of childhood-onset type 1 dia-
betes in two Scandinavian pregnancy cohorts (185,076 children; 
689 cases) and a Norwegian register-based cohort (434,627 chil-
dren; 692 cases). We measured cord blood cotinine as an objective 
marker of nicotine exposure during late pregnancy in 154 cases and 
476 controls. We also examined paternal smoking during preg-
nancy, in addition to environmental tobacco smoke exposure the 
first 6 months of life, to clarify the role of characteristics of smok-
ers in general.
Results: In the pregnancy cohorts, maternal smoking beyond gesta-
tional week 12 was inversely associated with type 1 diabetes, pooled 
adjusted hazard ratio (aHR) 0.66 (95% CI = 0.51, 0.85). Similarly, in 
the Norwegian register-based cohort, children of mothers who still 
smoked at the end of pregnancy had lower risk of type 1 diabetes, 
aHR 0.65 (95% CI = 0.47, 0.89). Cord blood cotinine ≥30 nmol/L 
was also associated with reduced risk of type 1 diabetes, adjusted 
odds ratio 0.42 (95% CI = 0.17, 1.0). We observed no associations of 
paternal smoking during pregnancy, or environmental tobacco smoke 
exposure, with childhood-onset type 1 diabetes.
Conclusion: Maternal sustained smoking during pregnancy is asso-
ciated with lower risk of type 1 diabetes in children. This sheds 
new light on the potential intrauterine environmental origins of the 
disease.
Keywords: childhood type 1 diabetes, father, mother, nicotine, 
smoking
(Epidemiology 2018;29: 848–856)
Together with known genetic influences, unidentified early environmental factors likely play a role in development 
of childhood-onset type 1 diabetes.1,2 Previous studies report 
inverse,3–7 positive,8 and null9,10 associations between mater-
nal smoking during pregnancy and type 1 diabetes in the off-
spring. Interestingly, most prospective studies suggest a lower 
risk of type 1 diabetes in offspring of mothers who smoked 
during pregnancy.2 One small study also indicated an inverse 
association between paternal smoking and type 1 diabetes.10
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The authors of previous studies indicating an inverse 
association between maternal smoking during pregnancy and 
risk of childhood-onset type 1 diabetes suggested unmea-
sured confounding and misclassification owing to reliance on 
self-reported information, as potential explanations.3–5 These 
studies all lacked an objective measure of exposure to mater-
nal smoking. The current weak evidence for similar inverse 
associations of both maternal and paternal smoking when the 
mother was pregnant with childhood-onset type 1 diabetes 
suggests that the associations might reflect unmeasured con-
founding by background characteristics linked to smoking in 
both parents.11,12
To test the hypothesis that maternal smoking during 
pregnancy is associated with a lower risk of type 1 diabetes, 
we wanted to further examine the role of unmeasured con-
founding and misclassification, using two of the world’s larg-
est pregnancy cohorts and a national register-based cohort. To 
examine the role of unmeasured confounding, we estimated 
the associations of paternal smoking and maternal smoking 
only before pregnancy with type 1 diabetes as negative con-
trols.13 To examine the potential role of recall bias attributable 
to self-report of maternal smoking during pregnancy, we also 
measured cord blood cotinine as a biomarker of exposure to 
nicotine during late pregnancy in a subsample of one of the 
pregnancy cohorts.
METHODS
The Norwegian Mother and Child Cohort 
Study and the Danish National Birth Cohort
The Norwegian Mother and Child Cohort Study 
(MoBa) recruited pregnant women across Norway between 
1999 and 2008, at approximately gestational week 18.14,15 
Of the eligible women, 41% participated, and all participants 
gave written informed consent. The cohort includes more than 
95,000 women and 114,500 children. We used data available 
in March 2014 (version VIII). A total of 98,287 singletons in 
MoBa with information from questionnaire administered at 
gestational week 18 were included in the current study (eFig-
ure 1 a; http://links.lww.com/EDE/B394). The data collection 
in MoBa is approved by the Norwegian Data Inspectorate, 
and the current subproject is approved by the Regional Ethics 
Committee for Medical Research of South East Norway.
The Danish National Birth Cohort (DNBC) recruited 
pregnant women at their first antenatal visit across Denmark 
between 1996 and 2002.16,17 Approximately 50% of all general 
practitioners in Denmark participated in the recruitment, and 
60% of invited women agreed to participate, resulting in 91,745 
mothers and 103,118 children. All participants provided writ-
ten informed consent. A total of 86,789 singletons from DNBC 
with information gathered through telephone interview at ges-
tational week 12 were included in the current study (eFigure 
1 b; http://links.lww.com/EDE/B394). The data collection in 
the DNBC is approved by the Danish National Ethics Board.
Norwegian National Registry Cohort
We also analyzed maternal smoking during pregnancy 
and childhood-onset type 1 diabetes in a Norwegian national 
register-based cohort. The linkage included information from 
the Medical Birth Registry of Norway, the Norwegian Prescrip-
tion Database, and the Norwegian Patient Registry, in addition 
to information on maternal education from Statistics Norway. 
The registry linkage included information on all deliveries in 
Norway between January 2004, when the prescription registry 
was set up, and December 2012 (n = 541,036). After exclu-
sion of children with a birth weight of 500 g or less (n = 419), 
gestational age of 22 weeks or less (n = 3,818), children with 
missing information on maternal smoking during pregnancy 
(n = 99,546), and children with missing maternal identifica-
tion number (n = 2,567), 434,686 children were eligible for 
the analysis. The national register linkage is approved by the 
Norwegian Data Inspectorate and the Regional Ethics Com-
mittee for Medical Research of South East Norway.
Parental and Household Smoking Based on 
Self-report
For the two pregnancy cohorts, we obtained self-reported 
information on parental frequency and amount of smoking 
before pregnancy (MoBa only), during pregnancy, and the first 
6 months of the child’s life, in addition to whether the child spent 
time in a room where someone was smoking the first 6 months 
of life. Maternal smoking during pregnancy was categorized 
as none (reference), only during the first 12 gestational weeks, 
and also after gestational week 12. In a secondary analysis in 
MoBa, we distinguished the reference category according to 
mothers who had never smoked and mothers who only smoked 
before pregnancy. We also did an exploratory analysis of the 
average number of cigarettes smoked per day during pregnancy, 
categorized as none, unknown (but reported smoking during 
pregnancy), ≤5, 6–10, and more than 10. Additional informa-
tion on exposure to paternal ([or] maternal partner) smoking 
the first 6 months of life was available for MoBa. In the analysis 
of the Norwegian register-based cohort, information on mater-
nal smoking during pregnancy was obtained through the birth 
registry and was categorized as none, only at the beginning of 
pregnancy, and still smoking at the end of pregnancy based on 
self-report at the time of delivery.
Cord Blood Cotinine Levels
We measured cord blood cotinine levels in 154 cases with 
type 1 diabetes and 476 randomly selected controls in MoBa. 
The sampling, processing, and storage conditions in the MoBa 
biobank have been described previously.18 The BEVITAL labo-
ratory, Bergen, measured cord blood cotinine levels in plasma 
using liquid chromatography–tandem mass spectrometry.19 
Cotinine levels were categorized as less than 1 nmol/L (not 
detectable), 1–29 nmol/L, and ≥30 nmol/L. A cotinine level 
≥30 nmol/L has previously shown a high correspondence with 
self-reported daily smoking among MoBa mothers.20
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Childhood-onset Type 1 Diabetes
The outcome in the two pregnancy cohorts (and nested 
case–control study) was a clinical diagnosis of type 1 diabe-
tes, ascertained by national Childhood Diabetes Registers, 
which are nationwide registers with a high level of case ascer-
tainment.21,22 Information on new cases of type 1 diabetes 
are reported from hospitals to the registers, and the date of 
first insulin treatment is used to define the age of onset. Rare 
cases of type 2 diabetes or monogenic diabetes were excluded 
from both registers. For the analysis in the Norwegian regis-
ter-based cohort, childhood-onset type 1 diabetes was defined 
based on dispensed prescriptions for insulin in the prescrip-
tion registry (Anatomical Therapeutic Chemical Classifica-
tion System code A10A) and/or a diagnosis of type 1 diabetes 
in the patient registry (International Classification of Diseases 
version 10 code E10). Individuals with only one registration 
of the International Classification of Diseases version 10 code 
E10, without any dispensed insulin in prescription registry, 
were excluded from analyses (n = 59) owing to their uncertain 
case status.
Covariates
Information on parental age, maternal parity, child sex, 
and birth weight were obtained from national birth registers. In 
addition, parental education and body mass index (weight kg/
height m2) were obtained through questionnaires/interviews 
in the two pregnancy cohorts. Finally, information on parental 
history of type 1 diabetes was obtained through the patient 
registry for MoBa participants, whereas maternal history of 
all types of diabetes was gathered through a national diabetes 
registry for DNBC participants.23 For the Norwegian register-
based cohort, maternal insulin-treated diabetes was defined 
as two or more dispensed prescriptions for insulin in the pre-
scription registry, and maternal educational level was available 
from statistics Norway. Participants in the case–control study 
of cord blood cotinine levels were also genotyped using a cus-
tom Illumina Golden Gate assay (Illumina, San Diego, CA). 
DNA extraction, genotyping methods, and quality control pro-
cedures have been described previously (see Ref. 24; details in 
supplementary Data; http://links.lww.com/EDE/B394). tag-
SNPs (n = 144) on chromosome 6 were used to impute human 
leukocyte antigen (HLA) class II genotype25 and confirmed 
by classical HLA genotyping using allele-specific polymerase 
chain reaction. HLA genotypes were categorized into two 
groups based on established risk for type 1 diabetes: increased 
risk (at least one copy of HLA DQA1*03-DQB1*03:02 
[DQ8-DR4] or DQA1*05:01-DQB1*02:01 [DQ2-DR3], and 
no protective HLA-DQA1*01:02-DQB1*06:02 haplotype) or 
no increased risk (any other genotype).
Statistical Analysis
We estimated the associations of parental and house-
hold smoking with childhood-onset type 1 diabetes using Cox 
proportional hazards regression, reporting hazard ratios (HR) 
and 95% confidence intervals (CI). We combined the results 
from the two pregnancy cohorts in a random-effects meta-
analysis. Heterogeneity between the cohort-specific estimates 
was examined by the I2 statistic. For the analysis of parental 
smoking during pregnancy, children were followed from date 
of birth until type 1 diabetes diagnosis or the end of follow-
up (21 July 2016 for MoBa, 15 May 2016 for DNBC, and 31 
December 2014 for the Norwegian registry-based cohort). In 
the analysis of environmental tobacco smoke exposure dur-
ing the first 6 months of life, the participants were followed 
from when they were 6 months of age. We used a robust clus-
ter variance estimator to account for the presence of siblings. 
The proportional hazards assumption was examined using the 
Schoenfeld residuals and testing the interaction with time. We 
used logistic regression to estimate the association between 
cord blood cotinine levels and childhood-onset type 1 diabetes 
in the MoBa case–control sample, reporting odds ratios (OR) 
and 95% CI.
The multivariable analysis of maternal smoking dur-
ing pregnancy and childhood-onset type 1 diabetes were 
adjusted for the mother’s age, parity, education, prepreg-
nancy body mass index, and diabetes, whereas in analyses 
of paternal smoking during pregnancy, we adjusted for the 
father’s age, education, body mass index, and type 1 diabe-
tes. These covariates were all considered to be confounders, 
although we acknowledge that smoking and body mass index 
have a complicated bidirectional relationship. For the analy-
sis of cord blood cotinine levels and risk of type 1 diabetes, 
we were also able to adjust for HLA genotype as a potential 
confounder. With regard to parental smoking during the first 
6 months of the child’s life, we further adjusted for paren-
tal smoking during pregnancy, in addition to the background 
characteristics described above. The analysis of the Norwe-
gian register-based cohort adjusted for maternal age, parity, 
education, and type 1 diabetes. We also examined the role of 
mediation by delivery by cesarean section, birthweight, and 
weight gain the first year of life for the association between 
maternal smoking during pregnancy and type 1 diabetes, by 
including these covariates in the multivariable model. This 
mediator model also adjusted for offspring sex as a potential 
confounder of the association between the pregnancy compli-
cations and type 1 diabetes.
The amount of missing information for the individual 
covariates ranged between 0% and 17%. We imputed in total 
20 datasets containing missing covariate information, using 
multiple imputation by chained equations, including all of the 
variables in the analysis model into the imputation model, in 
addition to the baseline hazard. We conducted the analysis 
using SAS version 9.4 (SAS Institute, Cary, NC) and Stata 
version 14 (StataCorp, College Station, TX).
RESULTS
A total of 185,076 children born between February 1998 
and July 2009 from MoBa and DNBC were available for the 
primary analysis after multiple imputation of missing exposure 
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and covariate information (eFigure 1; http://links.lww.com/
EDE/B394). The mean age of the children at the end of follow-
up was 11.0 years (range: 7.0–17.5 years) in MoBa and 15.5 
years (range: 13.0–18.2 years) in DNBC. The incidence rate 
of type 1 diabetes was 33 per 100,000 person-years in MoBa 
and 28 per 100,000 person-years in DNBC. Overall, the back-
ground characteristics in the two cohorts were similar (Table 1). 
The distribution of characteristics was similar among children 
included in the analysis after multiple imputation of missing 
covariate information and among children included in the com-
plete case analysis (eTable 1; http://links.lww.com/EDE/B394).
Paternal age (n [%])   
  Less than 25 4,837 (5) 3,713 (4)
  25–29 22,341 (23) 23,175 (27)
  30–34 37,929 (39) 34,298 (40)
  35+ 33,180 (34) 25,602 (30)
Paternal education (n [%])a   
  Less than high school (MoBa)/ 
nineth grade with exam (DNBC)
10,819 (11) 16,881 (20)
  High school (MoBa)/10th grade  
with exam (DNBC)
39,981 (41) 31,068 (36)
  Up to 4 years of college (MoBa)/ 
technical school (DNBC)
26,083 (27) 4,988 (6)
  More than 4 years of college (MoBa)/ 
high school or more (DNBC)
21,404 (22) 33,851 (39)
Paternal type 1 diabetes (n [%])   
  No 97,660 (99) NA
  Yes 627 (0.6) NA
Paternal BMI (n [%])   
  Underweight (<18.5) 223 (0.2) 674 (0.8)
  Normal weight (18.5–24.9) 43,921 (45) 44,036 (51)
  Overweight (25.0–29.9) 44,418 (45) 36,014 (42)
  Obese (≥30.0) 9,724 (10) 6,065 (7)
Paternal smoking during  
pregnancy (n [%])
  
  No 72,189 (74) 60,527 (70)
  Yes 26,098 (27) 26,262 (30)
Paternal smoking during the first 6 
months of the child’s life (n [%])
  
  No 76,561 (78) NA
  Yes 21,726 (22) NA
  Missing   
Household smoking during the first 6 
months of the child’s life (n [%])
  
  No 95,044 (97) 76,806 (89)
  Yes 3,243 (3) 9,983 (11)
Child sex (n [%])   
  Male 50,391 (51) 44,487 (51)
  Female 47,896 (49) 42,302 (49)
Child delivered by cesarean  
section (n [%])
  
  No 84,531 (86) 73,457 (85)
  Yes 13,756 (14) 13,331 (15)
  Uncertain 0 (0) 1 (0)
Child type 1 diabetes (n [%])   
  No 97,938 (99) 86,449 (99)
  Yes 349 (0.4) 340 (0.4)
BMI, body mass index; IQR, interquartile range.
aNote that the categories for parental education in the MoBa and the DNBC are not 
directly comparable.
bMaternal diabetes includes only type 1 diabetes in MoBa, whereas it includes all 
forms of diabetes in DNBC.
TABLE 1. (Continued)
Characteristic
MoBa  
(n = 98,287)
DNBC  
(n = 86,789)
TABLE 1. Distribution of Background Characteristics in the 
MoBa and the DNBC
Characteristic
MoBa  
(n = 98,287)
DNBC  
(n = 86,789)
Maternal age (median [IQR]) 30.0 (6.0) 30.2 (5.9)
Child birthweight (median [IQR]) 3,603 (670) 3,600 (700)
Child weight gain the first year of life in 
kg (median [IQR])
6.3 (1.4) 6.6 (1.5)
Child age at type 1 diabetes  
diagnosis in years (median [range])
7.10 (0.7–15.0) 10.1 (0.9–17.0)
Maternal parity (n [%])   
  Primiparous 44,033 (45) 40,747 (47)
  1 35,025 (36) 32,084 (37)
  2+ 19,229 (20) 13,958 (16)
Maternal education (n [%])a   
  Less than high school (MoBa)/ 
Nineth grade with exam (DNBC)
8,034 (8) 6,459 (7)
  High school (MoBa)/10th grade with 
exam (DNBC)
29,081 (30) 23,695 (27)
  Up to 4 years of college (MoBa)/ 
technical school (DNBC)
39,417 (40) 11,863 (14)
  More than 4 years of college  
(MoBa)/high school or  
more (DNBC)
21,755 (22) 44,771 (52)
Maternal prepregnancy BMI (n [%])   
  Underweight (<18.5) 3,115 (3) 3,911 (5)
  Normal weight (18.5–24.9) 64,220 (65) 58,441 (67)
  Overweight (25.0–29.9) 21,547 (22) 17,279 (20)
  Obese (≥30.0) 9,405 (10) 7,159 (8)
Maternal diabetes (n [%])b   
  No 97,829 (99) 84,460 (97)
  Yes 458 (0.5) 2,329 (3)
Maternal smoking during pregnancy (n [%])  
  No 75,005 (76) 63,743 (73)
  During the first 12 gestational  
weeks only
13,220 (14) 8,465 (10)
  Also after 12 gestational weeks 10,062 (10) 14,582 (17)
Maternal smoking the first  
6 months of the child’s life (n [%])
  
  No 83,951 (85) 70,268 (81)
  Yes 14,336 (15) 16,521 (19)
(Continued)
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Parental Smoking During Pregnancy and 
Childhood-onset Type 1 Diabetes in Two 
National Pregnancy Cohorts
eFigure 2 (http://links.lww.com/EDE/B394) shows the 
risk of type 1 diabetes by maternal smoking during preg-
nancy in MoBa and DNBC. For both cohorts combined, 
maternal sustained smoking during pregnancy was associ-
ated with a reduced risk of childhood-onset type 1 diabetes, 
with a pooled adjusted HR of 0.66 (95% CI = 0.51, 0.85) 
when comparing children of mothers who still smoked 
after gestational week 12 to children of mothers who did 
not smoke (Table 2). In contrast, paternal smoking during 
pregnancy was not associated with childhood-onset type 
1 diabetes, with a pooled adjusted HR of 0.97 (95% CI = 
0.82, 1.2; Table 2). The inverse association between mater-
nal smoking and childhood-onset type 1 diabetes was not 
mediated by birth weight, delivery by cesarean section, nor 
by infant weight gain the first year of life (eTable 2; http://
links.lww.com/EDE/B394). The complete case analysis 
yielded similar associations (eTable 3; http://links.lww.com/
EDE/B394). When we evaluated the association between the 
average number of cigarettes the mother smoked per day 
during pregnancy and childhood-onset type 1 diabetes, the 
estimates indicated some evidence for a dose–response rela-
tionship, but the modest number of cases within each expo-
sure group yielded imprecise confidence intervals (eTable 4; 
http://links.lww.com/EDE/B394). Interestingly, mater-
nal smoking only before pregnancy, that is, no intrauterine 
exposure, showed no association with type 1 diabetes in 
MoBa, adjusted HR 0.95 (95% CI = 0.73, 1.2). We observed 
some deviation from the proportional hazard assumption for 
maternal smoking during pregnancy in DNBC (p value for 
interaction with time 0.02), but the same was not observed 
for MoBa (p value >0.1).
Environmental Tobacco Smoke Exposure 
the First 6 Months of the Child’s Life and 
Childhood-onset Type 1 Diabetes
There was no strong evidence that exposure to mater-
nal smoking during the first 6 months of life, pooled adjusted 
HR 0.78 (95% CI = 0.55, 1.1), nor exposure to household 
smoking during the first 6 months of life, pooled adjusted 
HR 1.2 (95% CI = 0.83, 1.6), were associated with child-
hood-onset type 1 diabetes (Table 3). The results were 
similar in the complete case analysis (eTable 5; http://links.
lww.com/EDE/B394). In line with these findings, exposure 
to paternal smoking during the first 6 months of life also 
showed no strong evidence of an association with childhood-
onset type 1 diabetes in MoBa (eTable 6; http://links.lww.
com/EDE/B394). There was also some evidence for a devia-
tion from the proportional hazard assumption for the asso-
ciation between exposure to household smoking in MoBa 
TABLE 2. Associations of Parental Smoking During Pregnancy and Childhood-onset Type 1 Diabetes in the MoBa and the 
DNBC
Study
Maternal Smoking  
During Pregnancy Person-Years Events
Adjusteda  
HR (95% CI)
Heterogeneity  
p Value
  MoBa No 812,149 276 1  
First 12 gestational weeks 146,014 43 0.83 (0.59, 1.2)  
After 12 gestational weeks 117,300 30 0.67 (0.45, 0.99)  
  DNBC No 904,916 263 1  
First 12 gestational weeks 133,159 35 0.95 (0.66, 1.4)  
After 12 gestational weeks 171,744 42 0.65 (0.46, 0.90)  
  Combined No 1,717,065 539 1  
First 12 gestational weeks 279,173 78 0.88 (0.69, 1.1) 0.60
After 12 gestational weeks 289,044 72 0.66 (0.51, 0.85) 0.91
Study
Paternal smoking during  
pregnancy Person-years Events
Adjustedb HR  
(95% CI)
Heterogeneity  
p value
  MoBa No 780,557 251 1  
Yes 294,906 98 1.0 (0.79, 1.3)  
  DNBC No 862,634 242 1  
Yes 347,185 98 0.93 (0.73, 1.2)  
  Combined No 1,643,191 493 1  
Yes 642,091 196 0.97 (0.82, 1.2) 0.60
We imputed 20 datasets of missing exposure and covariate information by multiple imputation by chained equations and run analyses with these. This analysis takes into account 
uncertainty in the imputation.
aMaternal smoking during pregnancy adjusted for maternal age, parity, education, prepregnancy BMI, and diabetes (maternal type 1 diabetes in MoBa and all types of maternal 
diabetes in DNBC).
bPaternal smoking adjusted for paternal age, education, BMI, and diabetes (MoBa only).
BMI, body mass index.
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(p value for interaction with time 0.03), but the same was not 
observed for DNBC (p value >0.1).
Maternal Smoking During Pregnancy and 
Childhood-onset Type 1 Diabetes in the 
Norwegian Register-based Cohort
The risk of childhood-onset type 1 diabetes was simi-
lar among those included (n = 434,627) in the analysis of the 
Norwegian register-based cohort, and those excluded owing to 
missing exposure information (n = 106,409), with a HR of 1.1 
(95% CI = 0.96, 1.4). The mean age at the end of follow-up 
in the register cohort was 6.4 years (min 2.0, max 10.9). The 
overall incidence rate of type 1 diabetes among those included 
in the analysis was 25 per 100,000 person-years, and the mean 
age at onset was 4.7 years (min 0.2, max 10.5). The charac-
teristics of the children included in the analysis are shown in 
eTable 7 (http://links.lww.com/EDE/B394). The risk of type 1 
diabetes according to categories of maternal smoking is por-
trayed in eFigure 3 (http://links.lww.com/EDE/B394). Similar 
to the findings from the meta-analysis of the two pregnancy 
cohorts, children of mothers who still smoked at the end of 
pregnancy had decreased risk of type 1 diabetes, with an 
adjusted HR of 0.65 (95% CI = 0.47, 0.89; Table 4). There was 
no evidence that the association between maternal smoking 
during pregnancy and risk of type 1 diabetes was mediated by 
adverse pregnancy outcomes (eTable 8; http://links.lww.com/
EDE/B394). Including the 59 children with uncertain case sta-
tus in the analysis did not change our results.
Cord Blood Cotinine Levels and Childhood-
onset Type 1 Diabetes
The selection of the case–control sample with cord 
blood cotinine measures is illustrated in eFigure 4 (http://
links.lww.com/EDE/B394). There was an inverse association 
between cotinine levels in cord blood and childhood-onset 
type 1 diabetes after adjustment for potential confound-
ers, with an adjusted OR of 0.42 (95% CI = 0.17, 1.0) when 
comparing children with cotinine levels ≥30 nmol/L to those 
with nondetectable levels (Table 5). Additional adjustment for 
HLA genotype slightly attenuated the association. This result 
was similar (OR = 0.62; 95% CI = 0.22, 1.7) if we adjusted 
for HLA conferred risk in four categories (DQ8 and 2, HLA 
DQ8 or DQ2 but not DQ6, at least one DQ6 haplotype, or 
remaining genotypes; eTable 9; http://links.lww.com/EDE/
TABLE 3. Associations of Environmental Tobacco Smoke Exposure During the First 6 Months of Life and Childhood-onset  
Type 1 Diabetes in the MoBa and the DNBC
Study
Maternal Smoking at 
Child Age 0–6 Months Person-Years Events
Adjusteda HR 
(95% CI)
Heterogeneity 
p Value
  MoBa No 871,320 311 1  
Yes 155,707 38 0.70 (0.42, 1.2)  
  DNBC No 1,002,728 287 1  
Yes 207,091 53 0.86 (0.53, 1.4)  
  Combined No 1,874,048 598 1 0.77
Yes 362,798 91 0.78 (0.55, 1.1)  
Study
Household smoking  
at child 0–6 months Person-Years Events
Adjustedb HR 
(95% CI)
Heterogeneity 
p value
  MoBa No 989,965 334 1  
Yes 37,062 15 1.1 (0.64, 2.0)  
  DNBC No 1,050,488 298 1  
Yes 159,331 42 1.2 (0.78, 1.7)  
  Combined No 2,040,453 632 1  
Yes 196,393 57 1.2 (0.83, 1.6) 0.94
We imputed 20 datasets of missing exposure and covariate information by multiple imputation by chained equations and run analyses with these. This analysis takes into account 
uncertainty in the imputation.
aAdjusted for maternal smoking during pregnancy, age, parity, education, diabetes (maternal type 1 diabetes in MoBa and all types of maternal diabetes in DNBC), and prepregnancy 
BMI.
bAdjusted for parental (both maternal and paternal) age, education, diabetes (maternal type 1 diabetes in MoBa and all types of maternal diabetes in DNBC), BMI, and smoking 
during pregnancy, in addition to maternal parity.
BMI, body mass index.
TABLE 4. Association Between Maternal Smoking During 
Pregnancy and Childhood-onset Type 1 Diabetes in a 
Norwegian Register-based Cohort (n = 434,627)
Maternal  
Smoking
Person- 
Years Events
Adjusteda HR  
(95% CI)
No 2,347,735 605 1
Quit during pregnancy 172,222 43 0.88 (0.64, 1.2)
Still smoking at the 
end of pregnancy
245,999 44 0.65 (0.47, 0.89)
aAdjusted for maternal age, parity, education, and insulin-treated diabetes.
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B394). The complete case analysis also showed similar find-
ings (eTable 10; http://links.lww.com/EDE/B394).
DISCUSSION
In this study, based on two of the world’s largest preg-
nancy cohorts and a national register-based cohort, continued 
maternal smoking after the first trimester was associated with 
a reduced risk of childhood-onset type 1 diabetes. Based on 
our findings of no association with paternal smoking, and no 
association with maternal smoking only before pregnancy, 
we believe that there is no strong evidence of confounding by 
unmeasured background characteristics linked to smoking in 
both parents. Nor was the inverse association between mater-
nal smoking during pregnancy and type 1 diabetes likely to be 
explained by recall bias as a result of self-report, owing to the 
similar decreased risk of type 1 diabetes observed with high 
cord blood cotinine levels.
Important strengths of this study include the size, 
confirmation in two homogeneous pregnancy cohorts and 
a national registry linkage, adjustment for a broad range of 
potential confounding factors, inclusion of paternal smoking 
when the mother is pregnant as a negative control, and the 
objective marker of exposure to nicotine (cotinine) during late 
pregnancy. The low participation rate in the two cohorts, in 
addition to loss to follow-up, might have resulted in a selec-
tion bias.15,16 We used multiple imputation to account for 
missing information on individual covariates to include the 
largest possible number of participants in our analysis. Fur-
thermore, the association between maternal smoking during 
pregnancy and type 1 diabetes was similar when evaluated 
in the Norwegian register-based cohort, which included all 
deliveries in Norway within a given period, and this lends 
support to the notion that selection bias should not have 
greatly influenced the results of the two pregnancy cohorts. 
We observed some deviation from the proportional hazards 
assumption. Unfortunately, we did not have a sufficiently 
large number of cases to start dividing the follow-up time 
into intervals. Notably, the magnitude of the associations 
observed using logistic regression was similar. Despite some 
differences between the three cohorts in the way we were 
able to define maternal diabetes, multivariable adjustment for 
maternal diabetes did not change the estimated associations. 
We also acknowledge that our mediation analysis where we 
obtained an estimate of the conditional direct effect by includ-
ing the potential mediators in the multivariable model might 
be biased if there are unmeasured confounders of the asso-
ciation between the exposure and mediator or the association 
between the mediator and the outcome.26 Based on the fact that 
we observed no difference in the associations before and after 
multivariable adjustment for the hypothesized mediators, we 
do not think that there was strong evidence to support media-
tion. It also seems unlikely that any collider bias would have 
perfectly nullified any evidence of mediation.
In a previously published validation study compar-
ing maternal cotinine levels at approximately 18 gestational 
weeks to self-reported smoking status at the same time, the 
sensitivity and specificity for self-reported daily smoking, 
using 30 nmol/L as the cutoff concentration, were 82% and 
99%, respectively.20 Furthermore, when we compared self-
report of sustained smoking during pregnancy and cord blood 
cotinine levels, the sensitivity and specificity were 92% and 
95%, respectively. Based on the fact that we observed similar 
associations of both maternal self-reported smoking during 
pregnancy and cord blood cotinine levels with type 1 diabetes, 
we do not think that recall bias explained the observed inverse 
association.
Our findings are in line with previous studies reporting 
an inverse association after multivariable adjustment between 
maternal smoking during pregnancy and childhood-onset type 
1 diabetes.3–7 Most previous studies had a modest number of 
cases of type 1 diabetes, ranging between 196 and 361, except 
the first study that reported this association (with 2,757 cases 
of type 1 diabetes).7 The estimated association between mater-
nal smoking during pregnancy and childhood-onset type 1 
diabetes ranged between 0.76 (95% CI = 0.54, 1.1)3 and 0.37 
(95% CI = 0.22, 0.64).4 In addition, there is evidence from four 
case–control studies of children with a genetic predisposition 
to type 1 diabetes, which all show some evidence of an inverse 
association between maternal smoking during pregnancy and 
islet autoimmunity, but the confidence intervals included the 
null value.27–30 The only previous study that found evidence 
for an increased risk of type 1 diabetes among children of 
mothers who reported smoking in pregnancy consisted of 344 
cases and matched controls based on age and HLA haplo-
type.8 This study reported an almost four-fold increased risk 
of type 1 diabetes (OR: 3.9; 95% CI = 1.2, 12) among children 
of mothers who smoked 10 or more cigarettes per day during 
pregnancy, compared with children of nonsmoking mothers.8
Based on the positive association between maternal 
smoking during pregnancy and fetal death, we cannot exclude 
a potential selection bias attributable to the fact that we had 
to restrict our analysis to live births. If offspring who are mis-
carried/stillborn among smoking mothers would have had a 
greater risk of type 1 diabetes if they had survived, this could 
TABLE 5 Associations of Cord Blood Cotinine Levels and 
Risk of Type 1 Diabetes in the Case–Control Study Nested in 
the Norwegian Mother and Child Cohort Study
Cotinine  
Concentration
N  
Cases
N  
Controls
Adjusteda OR 
(95% CI)
Not detected 131 391 1
<30 nmol/L 15 44 0.82 (0.42, 1.6)
≥30 nmol/L 8 41 0.42 (0.17, 1.0)
We imputed 20 datasets of missing exposure and covariate information by multiple 
imputation by chained equations and run analyses with these. This analysis takes into 
account uncertainty in the imputation.
aAdjusted for maternal age, parity, education, prepregnancy BMI, and type 1 
diabetes.
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have contributed the inverse association between maternal 
continued smoking during pregnancy and type 1 diabetes. As 
indicated, multivariable adjustment for HLA genotype did not 
change the association between cord blood cotinine levels and 
risk of type 1 diabetes. Furthermore, if such selective loss of 
high-risk fetuses was a strong explanation for our findings, 
we would have expected to see similar inverse associations of 
maternal smoking before and after gestational week 12 with 
risk of type 1 diabetes. We, therefore, do not think that there 
is robust evidence to support that selective fetal death strongly 
influenced the observed associations.
The fact that we did not observe an association between 
paternal smoking and childhood-onset type 1 diabetes, nor an 
association with maternal smoking only before pregnancy (or 
only after), indicates that the association with maternal smok-
ing during pregnancy could be due to an in utero effect, as 
opposed to unmeasured background characteristics associated 
with parental smoking,11,12 This evidence is in contrast to what 
was proposed from the only previous study of paternal smok-
ing and childhood-onset type 1 diabetes, which included 65 
cases across two British cohorts.10 Furthermore, the fact that 
we observed a similar association between cord blood cotinine 
levels and childhood-onset type 1 diabetes in the MoBa cohort 
suggests that self-reporting of maternal smoking during preg-
nancy is not a major driver of the association.
Despite the obviously problematic public health mes-
sage of our findings, they support the possibility that maternal 
smoking during pregnancy may have a biologic influence on 
the risk of childhood-onset type 1 diabetes. Of note, the asso-
ciation was seen only for sustained smoking and not for those 
who stopped smoking early in pregnancy. This is in contrast to 
teratogens operating very early during development but simi-
lar to what is seen for effects of maternal smoking on birth 
weight.31 This indicates that the pathways involved are sus-
ceptible to modification in late gestation during rapid growth. 
Nicotine is known to have immune-suppressive actions.32 The 
possibility that these influences on the immune system could 
play a role in development of type 1 diabetes is supported by 
animal experiments, indicating that nicotine exposure reduces 
the incidence of type 1 diabetes by changing the profile of 
pancreatic cytokine expression from Th1 to Th2.33 Maternal 
smoking during pregnancy is also associated with a lower 
risk of preeclampsia,34 and adult smokers have reduced risk 
of Parkinson disease35 and ulcerative colitis.36 It is, therefore, 
interesting to speculate whether there might be any common 
mechanisms that might explain these observations.
Another possible biologic mechanism for an in utero 
effect of maternal smoking is differential DNA methyla-
tion.37,38 The top finding from the meta-analysis of multiple 
cohorts looking at maternal smoking and cord blood DNA 
methylation was cg05575921 in the aryl hydrocarbon receptor 
repressor (AHRR).37 AHRR suppresses signaling via the aryl 
hydrocarbon receptor, which may be involved in the regulatory 
T-cell and T-helper 17 function.39,40 Furthermore, a pathway 
analysis indicated that maternal smoking during pregnancy 
influenced pathways specific to T-cell function.41 Although the 
main underlying driver of many of the T-cell, eosinophil, and 
neutrophil pathway scores was GFI1, additional genes iden-
tified included IL22 and IL2RA.41 Of relevance to our find-
ings, a lower expression of IL2RA can influence immunity and 
potentially the risk of type 1 diabetes.42,43
Although our study shows robust evidence for an inverse 
association between maternal smoking during pregnancy and 
childhood type 1 diabetes, maternal smoking is known to be 
positively associated with several adverse pregnancy out-
comes (such as stillbirth,44 preterm birth,45 low birthweight,46 
and congenital malformations47) and chronic diseases (such as 
childhood asthma48 and overweight/obesity49). Any potential 
beneficial effect of maternal smoking on type 1 diabetes does 
not outweigh these potential harmful effects.
In conclusion, maternal sustained smoking during 
pregnancy is associated with lower risk of type 1 diabetes in 
children. This sheds new light on the potential intrauterine 
environmental origins of the disease. Further studies inves-
tigating the potential mechanisms underlying this association 
may lead to understanding of novel pathways for type 1 diabe-
tes and/or targets for prevention of the disease.
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